Consti Oyj
22.2.2021 07:24:18 CET | Globenewswire | Press release
CONSTI PLC Managers Transactions on 19 February 2021 at 2.20 p.m.
Consti Plc - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Salokangas, Kari Pekka
Position: Member of the Board/Deputy member
Issuer: Consti Plc
LEI: 743700JMXCC11CRJCS71
Notification type: INITIAL NOTIFICATION
Reference number: 743700JMXCC11CRJCS71_20210219131310_2
____________________________________________
Transaction date: 2021-02-19
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000178256
Nature of the transaction: DISPOSAL
Transaction details
(1): Volume: 369 Unit price: 12.45 EUR
(2): Volume: 5,624 Unit price: 12.4 EUR
(3): Volume: 1,007 Unit price: 12.35 EUR
Aggregated transactions
(3): Volume: 7,000 Volume weighted average price: 12.39544 EUR
CONSTI PLC
Further information:
Joni Sorsanen, CFO, Consti Plc, Tel. +358 50 443 3045
Distribution:
Nasdaq Helsinki Ltd.
Major media
www.consti.fi
Consti is a leading Finnish company concentrating on renovation and technical services. Consti offers comprehensive renovation and building technology services and selected new construction services to housing companies, corporations, investors and the public sector in Finland’s growth centres. Company has four business areas: Housing Companies, Corporations, Public Sector and Building Technology. In 2020, Consti Group’s net sales amounted to 275 million euro. It employs approximately 1000 professionals in renovation construction and building technology.
Consti Plc is listed on Nasdaq Helsinki. The trading code is CONSTI. www.consti.fi
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
King Faisal Specialist Hospital & Research Centre13.3.2026 22:15:53 CET | Press release
KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025
SCOR13.3.2026 18:59:39 CET | Press release
SCOR SE announces the availability of its 2025 Universal Registration Document
Novartis Pharma AG13.3.2026 18:35:19 CET | Press release
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
Luotea Oyj13.3.2026 18:30:00 CET | Press release
The Board of Directors of Luotea Oyj decided on updates to the company's share-based incentive plan for 2023-2027 and on the launch of a new share-based incentive plan for the years 2026-2030
Ilkka Oyj13.3.2026 18:00:00 CET | Press release
Ilkka Oyj: Acquisition of own shares on 13 March 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
